Elevate Bio

ElevateBio is a technology-driven advanced therapy contract development and manufacturing organization (CDMO) that partners with biopharmaceutical companies to design, develop, and manufacture cell and gene therapies from early discovery through commercialization. The company provides proprietary gene editing tools and services, cGMP manufacturing capabilities, and end-to-end support across cell therapies, gene edited therapies, RNA therapies, and mRNA vaccines. Operating from its flagship facility in Waltham, Massachusetts, ElevateBio combines continuous investment in automation and AI-assisted design with integrated process development and manufacturing under one roof to reduce timelines and costs for partners. The company serves programs at all stages, from preclinical supply through pivotal trials, BLA filing, and commercial production.